Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
NINTEDONE 150 Ninte
NINTEDONE 150 Ninte
COD not available
NEPHROLOGYRANGE by NINTEDONE 150

Nintedanib 150 mg

INR 900 INR 1050
You Save: INR 150 (14.29%)

Description

Product details

Introduction to Nintedanib 150 mg Nintedanib 150 mg is a widely prescribed medicine used in the management of serious lung conditions that cause progressive scarring and breathing difficulties. It belongs to a class of medicines known as tyrosine kinase inhibitors, designed to slow down the progression of lung fibrosis and improve overall respiratory health. Doctors commonly recommend Nintedanib 150 mg for patients suffering from conditions such as idiopathic pulmonary fibrosis (IPF), chronic fibrosing interstitial lung diseases (ILDs), and systemic sclerosis-associated interstitial lung disease. Patients searching for an effective medicine to manage worsening lung fibrosis often choose Nintedanib 150 mg because of its clinically proven effectiveness in slowing disease progression. With growing awareness about pulmonary fibrosis treatment, this medicine has become an important therapeutic option in respiratory care. What is Nintedanib 150 mg? f(x)=e −kx A k y=Ae −kt ≈6e −0.6t y t Nintedanib 150 mg capsules are oral prescription medicines formulated to reduce the rate of decline in lung function. It works by blocking pathways responsible for abnormal tissue scarring in the lungs. The medicine helps prevent further fibrosis and supports patients in maintaining better breathing capacity over time. Nintedanib is mainly prescribed for: Idiopathic Pulmonary Fibrosis (IPF) Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Systemic Sclerosis-Associated ILD Certain chronic pulmonary disorders involving fibrosis The medicine is generally taken twice daily or as directed by a healthcare professional. How Does Nintedanib 150 mg Work? Nintedanib 150 mg works by inhibiting multiple growth factor receptors involved in fibrosis formation. These receptors are responsible for the excessive production of fibrous tissue inside the lungs. By blocking these signals, the medicine slows the progression of lung scarring. This mechanism helps in: Slowing lung function decline Reducing fibrosis progression Improving breathing stability Supporting long-term respiratory health Unlike medicines that only relieve symptoms, Nintedanib focuses on controlling the progression of the disease itself. Key Benefits of Nintedanib 150 mg 1. Slows Disease Progression One of the major advantages of Nintedanib 150 mg is its ability to reduce the speed at which lung scarring worsens. This is especially important for patients with progressive pulmonary fibrosis. 2. Helps Maintain Lung Function Regular use may help preserve lung capacity and improve the patient’s ability to perform daily activities with reduced breathlessness. 3. Clinically Proven Therapy Nintedanib has been extensively studied in clinical trials and is considered an effective treatment option for fibrotic lung diseases. 4. Oral Capsule Form The medicine is easy to administer in capsule form, making treatment more convenient for long-term use. 5. Supports Quality of Life By slowing disease progression, patients may experience better mobility, reduced respiratory complications, and improved overall quality of life. Uses of Nintedanib 150 mg Idiopathic Pulmonary Fibrosis (IPF) IPF is a chronic lung disease that causes gradual scarring of lung tissue. Nintedanib helps slow the worsening of this condition. Progressive Fibrosing ILD Patients with fibrosing interstitial lung diseases may benefit from reduced progression and stabilized respiratory performance. Systemic Sclerosis-Associated ILD Nintedanib is also prescribed for lung complications related to systemic sclerosis, an autoimmune disorder. Chronic Lung Fibrosis Management Doctors may recommend Nintedanib 150 mg for other chronic pulmonary fibrosis conditions requiring anti-fibrotic treatment. Dosage and Administration Nintedanib 150 mg should always be taken exactly as prescribed by the healthcare provider. General Dosage Guidelines Usually taken twice daily Swallow capsules whole with water Preferably taken with food Maintain a consistent dosing schedule Patients should not crush, chew, or open the capsules unless advised by a medical professional. Important Precautions Before Using Nintedanib 150 mg Before starting treatment, patients should inform their doctor about: Liver disorders Heart disease Bleeding disorders Recent surgeries Pregnancy or breastfeeding Existing medications or supplements Routine monitoring may be required during treatment to assess liver function and overall health status. Possible Side Effects of Nintedanib 150 mg Like all medicines, Nintedanib 150 mg may cause side effects in some patients. Most side effects are manageable with proper medical supervision. Common Side Effects Diarrhea Nausea Vomiting Abdominal pain Loss of appetite Weight loss Serious Side Effects Seek immediate medical attention if you notice: Severe liver problems Chest pain Unusual bleeding Severe allergic reactions Difficulty breathing Patients should immediately consult their doctor if side effects become persistent or severe. Why Patients Choose Nintedanib 150 mg Patients and healthcare professionals prefer Nintedanib 150 mg due to its targeted anti-fibrotic action and long-term clinical benefits. It addresses the root mechanism of fibrosis progression rather than only symptom management. Key reasons behind its growing demand include: Proven effectiveness in IPF treatment Improved respiratory stability Better long-term disease management Trusted anti-fibrotic therapy Widely recommended by specialists Storage Instructions To maintain medicine effectiveness: Store below recommended temperature Keep away from direct sunlight Protect from moisture Keep out of reach of children Always check the packaging for detailed storage guidelines. Who Should Avoid Nintedanib 150 mg? Nintedanib may not be suitable for everyone. Patients with severe liver disease, high bleeding risk, or known hypersensitivity should avoid using this medicine unless specifically advised by a healthcare professional. Pregnant women should avoid this medicine due to potential risks to the unborn baby. Drug Interactions Nintedanib 150 mg may interact with certain medicines, including: Blood thinners Antibiotics Antifungal medicines Liver enzyme affecting drugs Herbal supplements Always provide a complete medication history to the doctor before starting treatment. Frequently Asked Questions About Nintedanib 150 mg Is Nintedanib 150 mg used for lung fibrosis? Yes, it is primarily used for treating pulmonary fibrosis and related lung disorders. Can Nintedanib cure pulmonary fibrosis? No, it does not cure the disease but helps slow down disease progression. How long should Nintedanib be taken? Treatment duration depends on the patient’s condition and doctor’s recommendation. Can I stop taking Nintedanib suddenly? Do not stop treatment without consulting your healthcare provider. Is Nintedanib a chemotherapy medicine? No, it is an anti-fibrotic medicine used mainly for lung diseases. Conclusion Nintedanib 150 mg is an advanced anti-fibrotic medicine widely used for managing progressive lung diseases such as idiopathic pulmonary fibrosis and interstitial lung disorders. Its ability to slow fibrosis progression and preserve lung function makes it an important treatment option for patients seeking long-term respiratory support.

Other Specifications

Brand Name :NINTEDONE 150
Manufactured By :Steris Healthcare Pvt Ltd
Package SIZE :For 10 Capsule
Storage :Store In A Cool & Dry Place
country :India
  • Filter tags

Have any question or need any business consultation?

Have any question or need any business consultation?

Contact Us
Chat with us